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Abstract: Major hindrances to getting a COVID-19 vaccine include vaccine hesitancy, skepticism, 
refusal, and anti-vaccine movements. Several studies have been conducted on attitudes of the public 
towards COVID-19 vaccines and the potential influencing factors. The purpose of this scoping re-
view is to summarize the data available on the various factors influencing public attitudes towards 
COVID-19 vaccination. This scoping review was conducted according to the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) 
Statement. PubMed, Embase, Web of Science, and Cochrane Central were searched without re-
strictions to reclaim all publications on the factors that shape individuals’ attitudes towards COVID-
19 vaccines from 1 January 2020 to 15 February 2021. Fifty studies were included. The scoping re-
view revealed that the factors influencing public attitudes towards COVID-19 vaccines were em-
bedded within the different levels of the socio-ecological model. These factors included the socio-
demographic characteristics of the individuals, individual factors, social and organizational factors. 
In addition, certain characteristics of COVID-19 vaccines themselves influenced public attitudes to-
wards accepting the vaccines. Understanding various population needs and the factors shaping 
public attitudes towards the vaccines would support planning for evidence-based multilevel inter-
ventions in order to enhance global vaccine uptake. 




Coronavirus disease 2019 (COVID-19) is a contagious and pathogenic viral infection 
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a specific type 
of coronavirus that was first discovered in Wuhan, China [1]. It was declared a global 
pandemic by the World Health Organization on the 11 March 2020. The pandemic caused 
by COVID-19 has infected more than 125 million people and killed at least 2.5 million 
globally and is becoming a leading cause of death [2]. This virus has become a major con-
cern around the globe, having so many consequences on the healthcare system and econ-
omy and instilling fear in communities [3,4]. The main mode of transmission is through 
droplets, direct contact with infected patients; it can also be transmitted through fomites, 
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by touching contaminated surfaces or objects [5]. People who are at increased risk of get-
ting severe infection include the elderly and those who have chronic diseases [6]. 
Although many efforts have been dedicated to the implementation of suppression 
strategies including travel bans, partial/full lockdown, contact tracing, and social distanc-
ing, the transmission of the virus is more likely to rebound when these strategies are lifted 
[7]. Consequently, for a long-term approach to combating this epidemic, the development 
and use of vaccines is essential [8]. 
Vaccination stimulates the immune system to develop antibodies to fight a specific 
infectious agent in the body [9]. They have been used to eliminate and significantly de-
crease morbidity and mortality associated with different infectious diseases [10] by 
providing benefit to those who get vaccinated and also protecting communities through 
reducing transmission of the disease [10]. Via herd immunity, a high uptake of COVID-
19 vaccines can also help protect people who cannot get a vaccine such as those with com-
promised immune systems and young children [11]. Getting efficacious results from a 
vaccine does not solely rely on accessibility/uptake, but also depends upon the public’s 
acceptance and willingness to get vaccinated [11]. Other major hindrances to getting a 
vaccine include vaccine hesitancy, skepticism, refusal, and anti-vaccine movements [12]. 
In 2019, vaccine hesitancy was identified as one of the ten challenges to global health [13], 
and this concern has grown throughout the COVID-19 pandemic [14]. While prior studies 
looked at predictors of vaccine acceptance and uptake, it is worth noting that emergency-
released vaccines differ from established vaccinations in many aspects [15], and newer 
vaccines are usually met with greater skepticism [16]. 
Several studies have been conducted on attitudes of the public towards COVID-19 
vaccines and potential influencing factors [15,17]. It is imperative to investigate the differ-
ent factors influencing attitudes and perceptions of people related to COVID-19 vaccines. 
Vaccine refusal has a variety of causes which differ depending on regional, cultural, and 
social factors [18]. Understanding different vaccine attitudes is particularly significant as 
diverse vaccine refusal strategies that address the needs of different groups can be devel-
oped [19]. In the light of the COVID-19 pandemic, there is an urgent need for a more com-
prehensive and detailed understanding of attitudes toward vaccines and the factors affect-
ing vaccine intention in order to adjust public health messages as appropriate [20]. There-
fore, in this scoping review, we sought to rapidly explore the determinants influencing pub-
lic attitudes with respect to COVID-19 vaccines and provide a more comprehensive and 
nuanced understanding of how these factors shape certain perspectives and behaviors. 
2. Materials and Methods 
This scoping review was conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) 
Statement (see Appendix A) [21]. The study has no written or published a priori protocol. 
Our research question was as follows: what are the factors influencing public attitudes 
with respect to COVID-19 vaccines? After identification of the research question, we iden-
tified relevant studies, selected the studies, charted the data, and collated, summarized, 
and reported the findings. 
2.1. Information Sources 
PubMed (National Library of Medicine, Bethesda, MD, USA), Embase (Elsevier, Am-
sterdam, Netherlands), Web of Science (Clarivate Analytics, Philadelphia, PA, USA), and 
Cochrane Central (Cochrane, London, UK) were searched without restrictions to reclaim 
all publications on the individual factors, sociocultural factors, and environmental factors 
that shape an individual’s decision (attitude) towards COVID-19 vaccines from 1 January 
2020 to 15 February 2021. Table 1 describes the search strategies used to collect published 
articles from the databases. Reference lists of the selected articles were also searched for 
articles that might have been missed in the online database search. 
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Table 1. Search strategies. 
Search Search Term 
#1 “Corona” OR “SARS-CoV-2” OR “COVID 19” 
#2 “Vaccine” OR “Vaccination” 
#3 
“Acceptance” OR “Agreement” OR “Willingness” OR “Refusal” OR “Resistance” OR 
“Confidence” OR “Hesitancy” OR “Antivaxx” OR “Antivaxxers” OR “Antivaccine” 
OR “Anti-vaccine” 
#4 #1, #2, and #3 
2.2. Eligibility Criteria 
In this scoping review, all the articles published between 1 January 2020 to 15 Febru-
ary 2021 about the factors that shape public attitudes towards COVID-19 vaccines were 
included. The articles selected were only in English, with human subjects aged 16 years 
and above, excluding healthcare workers who are obligated to get a vaccine. Articles were 
only included in English since it was the major language of the available articles in the 
databases at the time this search was conducted. 
Two authors independently screened abstracts and citations retrieved from the 
search and each author (out of the seven authors) was given a specific number of articles 
to assess full texts of the relevant records to be included in the review. When dealing with 
duplicates, the most recent version of the article with the largest sample size was included. 
During the study selection and assessment process, the first author was responsible for 
resolving any disagreements and final evaluation. 
2.3. Data Charting Process 
The relevant data were abstracted from the eligible articles in pre-structured data 
charting forms (Excel (Microsoft Corporation, Redmond, WA, USA) and Word (Microsoft 
Corporation, Redmond, WA, USA) documents). The following information was included: 
the first author of the study, publication year, study design, population, study setting, 
mean age of the participants (in years), sample size, attitude towards COVID-19 vaccines, 
and the various factors shaping these public attitudes. Descriptive statistics (percentages) 
were reported for some studies to reflect the rate of positive or negative attitudes towards 
the vaccines. The final column in the table reported percentages to reflect prevalence of 
the factors shaping the attitudes, and for some studies, the p-value was reported to reflect 
the significant association between the factors and public attitudes towards the vaccines. 
2.4. Synthesis of Results 
Description of the scope of literature was presented in tables according to the key 
levels of the socio-ecological model [22] which showed how a health determinant (public 
attitudes towards COVID-19 vaccines) can be influenced by the various factors embedded 
in different levels. In our review, we summarized and clustered the factors that influenced 
public attitudes towards COVID-19 vaccines into sociodemographic characteristics, indi-
vidual factors, and social and organizational factors. The final set of factors that were re-
lated to the specific characteristics of COVID-19 vaccines were summarized and reported 
in a separate table. 
2.5. Data Analysis 
Outcome data related to the factors that influence public attitudes towards COVID-
19 vaccines were summarized and clustered into the different levels of the socio-ecological 
model. Meta-analysis was not performed due to heterogeneity in the contextual and en-
vironmental factors including the healthcare system in the countries of the selected stud-
ies in our review.   




In total, 331 records were retrieved from the electronic database search. The remain-
ing records, after removing the duplicates, amounted to 274 records. After screening the 
titles and abstracts, 185 were excluded; the remaining 89 full-text articles were assessed 
for eligibility, and 50 studies were reserved for this review. The PRISMA diagram illus-
trates the study selection process and shows the reasons for exclusion for other studies 
(Figure 1). 
 
Figure 1. PRISMA flow diagram of study selection. 
3.1. Study Characteristics 
The studies were divided by design into one experimental study [23], 39 cross-sec-
tional studies [24–62], five literature reviews [63–67], one systematic review [68], one ran-
domized controlled trial [69], one longitudinal survey with two experiments [70], one Gal-
lup panel [71], one media analysis study through a proposed novel behavioral dynamics 
model SRS/I (susceptible–reading–susceptible/immune) for the microblogging platform 
Weibo on social media [72], and one conference paper [73]. The majority of these cross-
sectional studies reported their findings from one country, one study reported data from 
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19 countries [25], another study conducted legal analysis for several countries [40], and oth-
ers reported findings from two or three countries from Europe, America, Canada, and the 
Middle East [29,49,59]. The sample size of the reviewed studies ranged from 101 participants 
in an RCT study [69] to 13,426 participants in a survey conducted in 19 countries [25]. 
An online (web-based) survey was the most common data collection method applied 
in the cross-sectional studies in our review, of which: 
 Some studies reported using social media platforms including Facebook, Twitter, 
and LinkedIn to collect data [26,38,41,62,72]; 
 Some studies reported using specific platforms to upload surveys including 
crowdsourcing platform Amazon Mechanical Turk (mTurk, Amazon, Seattle, WA, 
USA) [32,61], computer-assisted web interviewing (CAWI) and computer-assisted 
telephone interviewing (CATI) [34,53], and Qualtrics (Seattle, WA, USA) [47,55]; 
 One study used an online questionnaire to examine public attitudes towards COVID-
19 vaccines in three phases: pre-lockdown, during lockdown, and post lockdown 
with different participants in every phase [41], and another study conducted two-
wave follow-up online surveys [55]; 
 One study used an online survey with a semi-structured questionnaire following the 
snowball sampling technique [60]; 
 One study used open-ended questions to ask about the factors influencing attitudes 
towards vaccines [47]; 
 One study used an Internet survey and telephone interviews [35]; 
 One study used a face-to-face-administered questionnaire [37]. 
The target populations in the majority of the reviewed articles were adults from the 
general public. The youngest participants were recruited in a study from Italy in which 
the age ranged from 15 to 85 years [53], and another study was conducted among parents 
and guardians aged 16 years and above who reported living in England with a child aged 
18 months or under [26]. Only three studies were conducted among populations with spe-
cific demographics such as the working population in Hong Kong (HK), China [52], peo-
ple with respiratory chronic diseases and older adults aged 65 and above [47,55], and the 
black American community in an RCT study [69]. 
The reported vaccine acceptance rate in the reviewed articles ranged from 29.4% to 
86% [23,24,26,45–49,51,72]. A study from the Middle East [49] reported a low rate of ac-
ceptance among the public from Jordan, Kuwait, and Saudi Arabia (29.4%), while a higher 
acceptance of 53.1% was reported in a study from Kuwait [48]. On the other hand, 86% of 
people in the UK expressed their willingness to receive a vaccine [47]. The information on 
the baseline characteristics of the selected studies can be found in Table 2.
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Table 2. Baseline characteristics of the selected studies. 
First Author/Year of 
Publication 
Study Design Study Setting Population Sample Size 
Mean Age 
(in Years) 
Attitudes towards COVID-19 Vac-
cines 
Chen, T.E. 2021 [23] Experimental design Online experiment Chinese adults 413 
Aged between 18 
and 60 (M = 
24.70, SD = 9.55) 
Attitudes towards COVID-19 vac-
cination scores were highly favorable 
and the intention to get vaccinated 
was high 
Chen, M.S. 2020 [24] Cross-sectional Online questionnaire Chinese adults 3195 
Majority aged 
18–44 
83.8% were willing to receive a 
COVID-19 vaccine, 13.6% were un-
sure 
Lazarus, J.V. 2020 
[25] 
Cross-sectional  19 countries (global) 13,426 
Majority aged 
25–54 
46.8% completely agreed to accept a 
COVID-19 vaccine 
Bell, S. 2020 [26] Cross-sectional survey 
Online social media strat-
egy 
Parents and guardi-
ans (aged 16+ years) 
who reported living 
in England with a 
child aged 18 months 
or under 
1190 33 
Acceptability of a future COVID-19 
vaccine 
Coustasse, A. 2020 
[63] 
Review  US population   
50% willing to get a vaccine in study 
1 







General public in 
Saudi Arabia 
992 
Most of the re-
spondents aged 
26–35 
Willingness to accept a vaccine 
Robles, A.S. 2020 [73] Conference paper  Nevada   Vaccine acceptance 
Wang, J. 2020 [28] Online cross-sectional survey Public China 2058 Adults Willingness to accept a vaccine 
Lin, C. 2021 [68] Systematic review   126 surveys  Vaccine intention and acceptance 
Murphy, J. 2021 [29] Cross-sectional survey Online survey 
General adult popula-
tions of Ireland and 





COVID-19 vaccine hesitancy and re-
sistance, including psychological in-
dicators 




General public in Tur-
key 
759 32.41 ± 9.92 Vaccination acceptance 
Vaccines 2021, 9, 548 7 of 25 
 
 




Australian adults (18 




Perceptions and behaviors towards a 
future COVID-19 vaccine 




chanical Turk (mTurk) 
Participants from the 
United States 
534 41.9 
Evaluation of COVID-19 vaccine de-
mand 
Biasio, L.R. 2020 [33] Online survey Online study Italian adults 885 
Majority aged 
31–50 
Perceptions about getting a vaccine 






sisted web interviewing 
(CAWI) 
Adult Greeks 1004 41.7 (17.7) 
Willingness to receive a COVID-19 
vaccine 
Fisher, K. 2020 [35] Cross-sectional survey 
Internet survey and tele-
phone interviews 
US general public 1000 Adults Vaccine hesitancy 
Guidry, J.P.D. 2021 
[36] 
Cross-sectional survey Online survey US adults 788 45.9 
Willingness to get a COVID-19 vac-
cine 
Jung, H. 2020 [70] 
Longitudinal survey, two ex-
periments 
 United states 
Survey: 2490 
Experiment: 800 
 Vaccination intention 






1647 Median age, 37 Vaccination acceptance 
Detoc, M. 2020 [38] Cross-sectional survey Online via social networks 
General population in 
France 
3250 Mostly 30–49 
Intention to get  
vaccinated against COVID-19 
Prati, G. 2021 [39] Online survey Online study General public in Italy 624 
Between 18 and 
72 years 
Willingness to accept a vaccine 
Marco-Franco, J.L. 
2021 [40] 
Cross-sectional, legal analysis  Several countries   Vaccine hesitancy 





down, and post-lockdown) 
Note: “different participants 
every phase” 
Various institutional and 
personal social channels 
related to the research 
team 
Italian residents 2267 25–65 
The percentage of people who ac-
cepted a vaccine was high during the 
lockdown 
Bogart, L.M. 2021 
[69] 
RCT Community-based Black Americans 101 50.3 (11.5) 
COVID-19 mistrust beliefs, COVID-
19 vaccine or treatment hesitancy 
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Alley, S.J. 2021[42] 
Repeated cross-sectional sur-
vey 
Online Australian adults 575 
Mostly over 55 
years 
Willingness to get vaccinated against 
COVID-19 
Puri, N. 2020 [64] Review Social media    Vaccine hesitancy 
Reiter, P.L. 2020 [43] Online survey Online study US general public 2006 >18 Willingness to accept a vaccine 
Feleszko, W. 2021 
[44] 
Poland, an online omnibus 
survey tool 
Public Poland public 1066 18–65 
37% supported COVID-19 vaccina-
tion 
Danchin, M. 2020 
[65] 
Review     Vaccine refusal 
Harapan, H. 2020 
[45] 
Cross-sectional online survey Online study 
General population in 
Indonesia 
1359 
More than half of 
the respondents 
were aged 21–30 
years 
50 or 95% effective COVID-19 vac-
cine 




Public China 3541 Adults 
83.5% said yes to the intent to get a 
vaccine 
Williams, L. 2020 
[47] 
Cross-sectional study with 
open-ended questions about 
the factors 
Online 
Older adults and peo-




with adults aged 
65 
86% of respondents wanted to re-
ceive a COVID-19 vaccine 
Yin, F. 2021 [72] 
Media analysis through a pro-
posed novel behavioral dy-




Weibo (social media) 
Chinese citizens (liv-









Public (adults living in 
Kuwait) 
Kuwait 2368 >21 
Participants were willing to accept a 
COVID-19 vaccine once available 
(53.1%) 
Sallam, M. 2021 [49] Cross-sectional online survey Online study 
Jordan, Kuwait, and 
Saudi Arabia 
3414  Vaccine acceptance (29.4%) 
Wong, L.P. 2020 [50] Cross-sectional online survey Online survey 
Malaysian general 
public 
1159 Adults Willingness to accept a vaccine 




Internet survey US general public  Adults Willingness to accept a vaccine 
Wang, K.L. 2021 [52] Cross-sectional Online questionnaire 
Working population 





Standardized rate of vaccine ac-
ceptance in the first survey was 
44.2% and 34.8% in the second sur-
vey 
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Largent, E.A. 2020 
[71] 
Gallup panel Online study US adults 2730 Not available Acceptability of COVID-19 vaccines 




Online using computer- 
assisted web interviews 
(CAWI) 
Italians aged 15–85 
years 
1055 33.2 
Attitudes towards a potential 
COVID-19 vaccine 
Ward, J.K. 2020 [54] Cross-sectional survey Online 
French  
population of 18 years 
of age 
5018 
Mostly less than 
35 
Attitudes to a future COVID-19 vac-
cine 
Romer, D. 2020 [55] Two-wave follow-up surveys Online using Qualtrics 
US general popula-
tion 
1050 Mostly 60+ 
Intention to get vaccinated against 
COVID-19 
Sherman, S.M. 2020 
[56] 
Cross-sectional online survey Online study UK adults 1500 46 ± 15.8 Vaccination intention 
McCaffery, K.J. 2020 
[57] 
National cross-sectional com-
munity online survey 
 
Australian general 
public, adults aged 
over 18 years 
4362 42.6 ± 17.4 Vaccine hesitancy 
Pogue, K. 2020 [58] Cross-sectional survey Public online survey US respondents 316  COVID-19 vaccine intention 
Taylor, S. 2020 [59] Cross-sectional survey 
Public Internet-based 
study 
American and  
Canadian adults 
3674 53 ± 15 Vaccination hesitancy 
Reuben, R.C. 2020 
[60] 
Cross-sectional online survey 
with a semi-structured ques-
tionnaire using a snowball 
sampling technique 
Public North-central Nigeria 589 
80.6% were 18–39 
years 
29% accepted to take a vaccine 
Corpuz, R. 2020 [61] 
Cross-sectional Amazon’s 
Mechanical Turk (MTurk), an 
online survey tool 
Online study US general public 209 
Mean age M = 
33.4 years (SD = 
11.4) 
Endorsement of the vaccines 
Bertin, P. 2020 [62] 
Two cross-sectional studies. 
An online questionnaire was 
disseminated by the authors 
on Facebook, Twitter, and 
Linkedin 
Online studies 
General public in 
France 
396 
Mage = 26.1, SD = 
10.3, min = 18, 
max = 70 
Negatively predicted participants in-
tention to get the vaccine 
Ling, R. 2020 [66] Review Social media    Anti-vaccination 
Dube, E. 2020 [67] Review     Vaccine hesitancy 
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3.2. Sociodemographic Characteristics Shaping Public Attitudes towards COVID-19 Vaccines 
Twenty-eight studies depicted the sociodemographic factors associated with public 
attitudes (Table 3). Age [23,25,27,29,31,34–36,38,51–53,63,65,73], educational level [23–
25,27,30,35,36,42,47,49–51,63,65,68,71,73], gender [24,25,28–32,34,38,48,49,51,52,65,68], 
race [26,29,35,36,47,51,63,68,71,73], and income status [24–26,29,47,50,51,63,65,68] were 
the most common factors reported. White individuals older than 25 years who have a high 
education level and high-income status were more likely to report positive attitudes to-
wards the vaccines. The majority of the reviewed studies reported that men were more 
willing to accept a vaccine than women [28–30,38,48,49]. Only one study in the USA re-
ported higher willingness among men [32]. 
Moreover, other factors were included, such as health condition, people with chronic 
diseases [29,31,49,65,73], occupation status [27,30,46,50,53,73], marital status [27,28,52], 
place of residence [29,51,68,73], women being pregnant [29] or having children [30], and 
those who have health insurance or not [30,31,36,51]. The reviewed articles showed that 
individuals who had chronic diseases, were employed, married with children, and had 
health insurance were more likely to report acceptance of COVID-19 vaccines. 
Table 3. Sociodemographic characteristics associated with hesitancy or acceptance of COVID-19 vaccines. 
First Author 
Hesitancy (−) or Acceptance (+) of 
COVID-19 Vaccines  
Sociodemographics Shaping Public Attitudes towards 
COVID-19 Vaccines 
Chen, T.E. 2021 [23] + 
- High education level 
- Increasing age 
Chen, M.S. 2020 [24] + 
- Male gender 
- High income 
- Education level 
- Han nationality 
Lazarus, J.V. 2020 [25] 
+ 
- Age older than 25 
- Male gender 
- High income 
- High education level 
− - Sick people or sick family members 
Bell, S. 2020 [26] − 
- Black, Asian, Chinese, mixed, or other ethnicity 
- Low income 
Coustasse, A. 2020 [63] + 
- 60 years and older 
- Non-Hispanic Whites 
- High education level 
- High income 
Al-Mohaithef, M. 2020 [27] − 
- Older age 
- Being married 
- High education level 
- Non-Saudi 
- Employed in the government sector 
Robles, A.S. 2020 [73] + 
- Age 
- Ethnicity 
- Chronic disease 
- Education level 
- Employment status 
- Country 
Wang, J. 2020 [28] + 
- Male gender 
- Being married 
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Lin, C. 2021 [68] + 
- College degrees 
- Income, 
- Insurance 
- Living in rural or larger areas 
- Gender 
- Race  
Murphy, J. 2021 [29] − 
Irish sample, vaccine-hesitant 
- Female gender 
- Aged between 35 and 44 years 
- No mental health problem 
Irish sample, vaccine-resistant 
- Aged 35–44 years 
- Residing in a city 
- Non-Irish ethnicity 
- Lower income  
- Underlying health condition 
UK sample, vaccine-hesitant 
- Female gender 
- Younger than 65 
UK sample, vaccine-resistant 
- Younger age 
- More likely to reside in a suburb 
- In the three lowest income brackets 
- Being pregnant 
Akarsu, B. 2020 [30] 
− 
- Female gender 
- Unemployed 
+ 
- Have SSI or private health insurance 
- Have children 
- Those who were thinking about getting their child a 
COVID-19 vaccine were more willing to get vaccinated 
- High level of education 
Seale, H. 2021 [31] + 
- Female gender 
- Aged 70 years and above 
- Reporting chronic disease 
- Holding private health insurance 
Hursh, S.R. 2020 [32] − - Male gender  
Kourlaba, G. 2021 [34] + 
- Aged > 65 years old 
- Those belonging to vulnerable groups or members of 
their household belonging to vulnerable groups 
Fisher, K. 2020 [35] - 
- Young age 
- Black race 
- Low educational attainment 
Guidry, J.P.D. 2021 [36] + 
- Education 
- Having insurance 
- Age 
- Race/ethnicity 
Detoc, M. 2020 [38] + 
- Older age, 
- Male gender 
Alley, S.J. 2021 [42] − 
- Low education 
- Female gender 
Danchin, M. 2020 [65] − 
- Low education 
- Low income 
- Potentially more prone to infectious diseases 
- Women aged < 35 years 
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- People aged > 75 years who are at a higher risk of disease 
from COVID-19 
Lin, Y. 2020 [46] + - Self-employed and service sector workers 
Williams, L. 2020 [47] + 
- White ethnicity 
- High education level 
- High income 
- High-risk/shielding 
Alqudeimat, Y. 2021 [48] + - Male gender 
Sallam, M. 2021 [49] + 
- Male gender 
- High education levels 
- History of chronic disease 
Wong, L.P. 2020 [50] + 
- Higher education levels 
- Professional and managerial occupations 
- High income 
Nguyen, K.H. 2020 [51] − 
- Young adults 
- Female gender 
- Non-Hispanic Black (Black) persons 
- Adults living in nonmetropolitan areas 
- Adults with lower educational attainment 
- Low income 
- No health insurance 
Wang, K.L. 2021 [52] + 
- Young age  
- Male gender 
- Being married 
Largent, E.A. 2020 [71] + 
- Non-Black respondents more likely to get vaccinated 
- Respondents with a bachelor’s degree or higher  
LaVecchia, K. 2020 [53] + 
- Age above 55 
- Professionals, managers, teachers, and manual workers 
3.3. Individual Factors Shaping Public Attitudes towards COVID-19 Vaccines 
Several individual factors influencing public attitudes were reported in thirty-six 
studies (Table 4). Personal beliefs with regard to vaccines and COVID-19 
[30,32,34,35,49,55–57,62,66,68,70], health literacy [33,65], knowledge [34,37,57,68], lack of 
trust in governments and companies producing the vaccines [25,35,37,39,59], perceived 
susceptibility and risk perception towards COVID-19 and side effects of the vaccines 
[24,28,36,38,45–48,56], social [61,70], religious [37], and political views [29,32,54,61,71], 
level of anxiety of getting infected [30], fear [24,30,37,38] and worries [39,59], confidence 
in academic institutions and producing companies [24,60], preference towards natural im-
munity [40], previous experience with flu vaccines or other vaccines [28,30,52,56,58], like-
lihood of infection and severity of the disease [41,43,48,58] were all considered as individ-
ual factors in this scoping review. 
Our review showed that the individuals who believe that coronavirus is contagious 
and lethal, have good knowledge and score high on health literacy, are stressed, worried, 
and anxious about getting infected, trust the healthcare system, the government, and the 
companies producing the vaccines, and have positive experience with previous vaccines 
were more likely to accept COVID-19 vaccines than others. On the other hand, the indi-
viduals with greater conspiracy beliefs and political conservatism, and those with per-
sonal reasons to refuse a vaccine, including religious conviction, were hesitant and re-
ported negative attitudes towards COVID-19 vaccines.   
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Table 4. Individual factors associated with hesitancy or acceptance of COVID-19 vaccines. 
First Author 
Hesitancy (−) or Acceptance (+) 
of COVID-19 Vaccines  
Individual Factors Shaping Public Attitudes Towards COVID-
19 Vaccines 
Chen, M.S. 2020 [24] + 
- Confidence, satisfaction, and worries about risks 
- Attention to relevant COVID-19 information 
- Perceived views of the severity of COVID-19 disease 
- Degree of concern regarding the COVID-19 pandemic 
Lazarus, J.V. 2020 [25] + - Trust in the government 
Wang, J. 2020 [28] + 
- Perceiving a high risk of infection 
- Being vaccinated against influenza in the previous season 
Lin, C. 2021 [68] − 
- Belief that vaccines are unnecessary 
- Inadequate information 
- General anti-vaccine stand 
- Willingness to pay 
Murphy, J. 2021 [29] − 
- Irish sample: more likely to have voted for the political party 
Sinn Féin or an independent politician in the previous general 
election 
Akarsu, B. 2020 [30] 
+ 
- Got a seasonal flu vaccine 
- High level of anxiety 
− 
- “Afraid of the side effects of the vaccines” 
- “Do not think it can be reliable as it will be a new vaccine” 
- “COVID-19 infection is a biological weapon” 
- “The vaccine will serve those who produce this virus” 
Hursh, S.R. 2020 [32] − - Greater conspiracy beliefs and political conservatism 
Biasio, L.R. 2020 [33] Attitudes to a COVID-19 vaccine - Health literacy 
Kourlaba, G. 2021[34] + 
- Those believing that the COVID-19 virus was not developed in 
laboratories by humans 
- Those believing that coronavirus is far more contagious and le-
thal compared to the H1N1 virus 
- Those believing that next waves are coming 
- Higher knowledge score regarding symptoms, transmission 
routes, and prevention and control measures against COVID-19 
Fisher, K.A. 2020 [35] − 
- Vaccine-specific concerns  
- Need for more information 
- General anti-vaccine beliefs 
- Lack of trust  
Guidry, J.P.D. 2021 [36] 
 
+ 
- Positive subjective norms 
- A positive attitude toward vaccines in general 
- Perceived susceptibility to COVID-19 
- High perceived benefits of the vaccines 
- Scoring low on barriers to the vaccines 
- Scoring high on self-efficacy 
- High perceived behavioral control 
Jung, H. 2020 [70] + 
- Prosocial concern for vaccination motivates vaccination in 
more and less populated regions 
Popa, G.L. 2020 [37] − 
- Lack of information 
- Fear of adverse reactions 
- Fears of toxicity and poor quality related to vaccine compo-
nents 
- Doubts about the technology used to produce the vaccines 
- Personal reasons to refuse vaccines (which included religious 
conviction) 
- Lack of trust in the healthcare system 
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Detoc, M. 2020 [38] + - Fear about COVID-19 and individual perceived risk 
Prati, G. 2021 [39] Attitudes to a COVID-19 vaccine 
- Being worried about the non-natural origin of the virus and the 
role of the institutional trust 
Caserotti, M. 2021 [41] + 
- Likelihood of getting the infection 
- Perceived severity of the disease 
Reiter, P.L. 2020 [43] + 
- Likelihood of getting the COVID-19 infection in the future 
- Perceived severity of the COVID-19 infection 
Danchin, M. 2020 [65] + - Adequate health literacy 
Harapan, H. 2020 [45] + - Perceived risk of the COVID-19 infection 
Lin, Y. 2020 [46] + 
- Perceiving overall health as very good 
- Perceiving the benefit of feeling less worried of contracting 
coronavirus after getting a vaccine 
- Perceiving the benefit of a COVID-19 vaccine in reducing the 
risk of infection and resultant complications 
- If given adequate information and if taken by many in the gen-
eral public 
Williams, L. 2020 [47] 
Attitudes to a COVID-19 vaccine 
 
- The perception that COVID-19 will persist over time 
- Perceiving the media to have overexaggerated the risk 
- The “beliefs about consequences” TDF domain, with themes 
relating to personal health, health consequences to others, and 
severity of COVID-19 
Alqudeimat, Y. 2021 [48] − 
- Likelihood of infection 
- Viewed vaccines in general to have health-related risks  
Sallam, M. 2021 [49] − 
-Beliefs that COVID-19 vaccines are intended to inject micro-
chips into recipients and that the vaccines are related to infertil-
ity 
Wang, K.L. 2021 [52] + 
- Influenza vaccine uptake during the previous year 
 
Largent, E.A. 2020 [71] − 
- Republicans and Independents were less likely to get vac-
cinated than Democrats 
Ward, J.K. 2020 [54] 
 
Attitudes to a COVID-19 vaccine 
 
- Political partisanship and engagement with the political system 
Romer, D. 2020 [55] − - Belief in three COVID-19-related conspiracy theories  
Sherman, S.M. 2020 [56] + 
- Having been vaccinated for influenza the previous winter 
- Perceiving a great risk of COVID-19 
- Positive general COVID-19 vaccination beliefs and attitudes 
- Weak beliefs that the vaccination would cause side effects 
- Greater perceived information sufficiency to make an informed 
decision about COVID-19 vaccination 
- Lower endorsement of the notion that only people who are at 
risk of serious illness should be vaccinated for COVID-19 
 
McCaffery, K.J. 2020 [57] − 
- Beliefs and misinformation about COVID-19/vaccines  
- Inadequate health literacy 
Pogue, K. 2020 [58] + 
-Respondents who routinely got vaccines were more likely to be 
receptive to receiving a COVID-19 vaccine 
-The greater the perceived impact of COVID-19 in America, the 
more receptive the respondent was to receive a potential 
COVID-19 vaccine 
Taylor, S. 2020 [59] − 
- Mistrust of vaccine benefits 
- Worries about unforeseen future negative effects 
- Concerns about commercial profiteering 
- Preference for natural immunity 
Reuben, R.C. 2020 [60] − - No confidence in the present intervention by Chinese doctors  
Corpuz, R. 2020 [61] + 
- Those exhibiting a slow life history orientation were more 
likely to endorse mandatory vaccination for COVID-19 
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− - Social and political conservatism 
Bertin, P. 2020 [62] − - COVID-19 conspiracy beliefs 
Ling, R. 2020 [66] − 
- Confirmation bias, consumption of only those news that con-
firm the pre-existing attitudes and beliefs 
3.4. Social and Organizational Factors Shaping Public Attitudes towards COVID-19 Vaccines 
Table 5 represents the articles that discussed the role of family, friends, healthcare 
providers, and employers in shaping public attitudes. In addition, it depicts the articles 
discussing the role of traditional (classic) and social media. Social networks and organiza-
tional factors that affect the attitude toward COVID-19 vaccines were reported in 10 stud-
ies. Social service and healthcare providers and the physician’s recommendation of vac-
cination [28,43,44,69] were the most prevalent ones. The individuals who were advised by 
a physician or any other healthcare provider to take a vaccine were more likely to have a 
positive attitude towards it than those who did not get any advice. The employer’s rec-
ommendation might also influence an individual’s attitude positively [25]. 
The influence of traditional media [42], type of messages received, and disinfor-
mation through the Internet and social media [23,37,64] were among the reported factors. 
The reviewed articles showed that misleading information shared on social media plat-
forms would make individuals hesitant to take the vaccine. In addition, 78% of the partic-
ipants in one study stated that their decision to get a vaccine was supported by their fam-
ily and friends [31], especially when someone of their family members or friends was vac-
cinated [44]. 
Table 5. Social and organizational factors associated with hesitancy or acceptance of COVID-19 vaccines. 
First Author 
Hesitancy (−) or Acceptance (+) 
of COVID-19 Vaccines  
Social Networks and Organizational Factors (Family, Friends, HC 
providers, Employers) and Media Shaping Public Attitudes towards 
COVID-19 Vaccines 
Chen, T.E. 2021 [23] + 
- Type of messages received and message frames 
- Outcome uncertainty 
- Number format 
- Numeracy skills 
Lazarus, J.V. 2020 [25] + - Accepting their employer’s recommendation to do so 
Wang, J. 2020 [28] + - Valuing their doctor’s recommendations 
Seale, H. 2021 [31] +/− 
- Decision to get vaccinated would be supported by family and 
friends 
Popa, G.L. 2020 [37] − 
- Disinformation (through classic media, social media, and the Inter-
net) 
Bogart, L.M. 2021 [69] + - Social service and healthcare providers 
Alley, S.J. 2021 [42] − - Infrequent users of traditional media 
Puri, N. 2020 [64] − - Anti-vaccination messages on social platforms 
Reiter, P.L. 2020 [43] + - Healthcare providers recommending vaccination 
Feleszko, W. 2021 [44] + 
- Recommended by a family doctor 
- Someone of family members/friends was vaccinated 
- Need a vaccination certificate to enter some countries 
3.5. Characteristics of COVID-19 Vaccines and Public Concern 
Table 6 summarizes the literature that shows how some vaccine characteristics affect 
public attitudes. Efficacy [28,40,43,45,46,63,65,68,73], safety [25,28,35,47,63,65,68,73], cost 
[46,63,68,72], and adverse effects or toxicity of the vaccine [37,40,46,47,63,68,72,73] were 
among the vaccine characteristics that were reported to shape public concerns about 
COVID-19 vaccines. The reviewed articles showed that the individuals who had a nega-
tive perception towards vaccine efficacy, safety, and side effects would report unwilling-
ness and hesitancy towards taking a vaccine. 
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Furthermore, immunity duration [68], timeframe of vaccination [63], fake or low-
quality vaccines [46], country of vaccine origin [24,68] and information about inactivated 
vaccines [72] were other public concerns in the selected studies. The individuals who be-
lieved that immunity boosted by a vaccine would be for a short period, vaccine develop-
ment was expedited, and the production process was pushed, and that the vaccines are 
most probably fake would report negative attitude towards COVID-19 vaccines. 
Table 6. Characteristics of COVID-19 vaccines associated with hesitancy or acceptance of the vaccines. 
First Author 
Hesitancy (−) or Acceptance (+) 
of COVID-19 Vaccines  
Characteristics of COVID-19 Vaccines Shaping Public Attitudes 
towards COVID-19 Vaccines 
Chen, M.2020 [24] + - If the vaccine is domestic, not imported 
Lazarus, J.V. 2020 [25] + - Vaccine proved safe and effective by the government 
Coustasse, A. 2020 [63] +/− 
- Effectiveness estimate of the vaccine 
- Safety based on newness and adverse effects 
- Lack of testing 
- Vaccination timeframe  
- Who will have access to it 
- Cost to consumers  
- How states and the federal government will determine vaccination 
methods 
- Getting COVID-19 from the shot 
- Fear of side effects from an untested vaccine 
Robles, A.S. 2020 [73] +/− 
- Perception of efficacy, safety, and adverse effects of the vaccines 
- Source of information 
- Conspiracy theories 
- Reactance and outrage regarding new information 
Wang, J. 2020 [28] +/− 
- Efficacy of COVID-19 vaccination 
- Concerns about vaccine safety 
Lin, C. 2021 [68] +/− 
- Newness of COVID-19 vaccines 
- Inadequate information 
- Unknown/short duration of immunity 
- Cost 
- Country of vaccine origin 
- Fear of side effects, safety, and effectiveness 
Fisher, K.A. 2020 [35] − 
- Vaccine-specific concerns 
- Need for more information 
Popa, G.L.P. 2020 [37] − 
- Fear of adverse reactions 
- Fear of toxicity and poor quality related to vaccine components 
- Doubts about the technology used to produce the vaccines 
- Price 
Marco-Franco, J.E. 2021[40] − 
- Worries about the side effects, safety and effectiveness of the vac-
cines 
Reiter, P.L. 2020 [43] + - Effectiveness of a COVID-19 vaccine 
Danchin, M. 2020 [65] + - Vaccine safety and effectiveness 
Harapan, H. 2020 [45] + - The baseline effectiveness of the vaccines 
Lin, Y. 2020 [46] +/− 
- Concerns about faulty/fake vaccines 
- Affordability and high price 
- Safety and efficacy 
- Confidence and preference of domestically made vaccines 
Williams, L. 2020 [47] +/− - Personal concerns regarding vaccine safety 
Yin, F. 2021 [72] + 
- The majority thought the price was low 
- Positive views on side effects 
- Information about inactivated vaccines (inactivated vaccines are 
more accepted) 
Wang, K.L. 2021[52] − - Doubts of effectiveness 
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- Thought of the vaccines as unnecessary 
- More accepted in the first wave compared to the third wave 
Dube, E. 2020 [67] − 
- Vaccine development is being pushed 
- COVID-19 vaccine antigen-carrying platforms have never been 
used 
- The production of new COVID-19 vaccines will not meet demand 
- Conspiracy theories 
- More than one type of COVID-19 vaccines is likely to be used 
within a country. Thus, the safety and efficacy profiles may vary 
4. Discussion 
This scoping review of 50 articles systematically maps evidence on the influencing 
factors that may lead to COVID-19 vaccine hesitancy worldwide. Vaccine hesitancy and 
anti-vaccination movements represent an old phenomenon that threatens global health 
[74–77]. With the current situation of the COVID-19 pandemic, this can be a stumbling 
block in the global efforts to control the disease and its devastating consequences. 
Vaccination is considered a vital element for public health; it is the most effective 
intervention for the primary prevention of communicable diseases. To enhance ac-
ceptance and uptake of vaccines, it is crucial to gain insight into the common factors that 
influence an individual’s decision-making process to help inform policymakers to de-
velop effective strategies. This scoping review updates the latest information on the de-
terminants that impact COVID-19 vaccine uptake. The review included studies that re-
ported global data which offer an insight on how public attitudes towards COVID-19 vac-
cination varies around the world. It also demonstrated that these attitudes are influenced 
by a wide range of factors on multiple levels of the socio-ecological model. Sizeable evi-
dence showed that sociodemographic factors such as age, gender, and income status, in-
dividual factors such as personal beliefs and risk perception, and social and organizational 
factors such as the role of significant others are among the most related determinants. In 
addition, certain characteristics of the COVID-19 vaccines themselves like efficacy, safety, 
and side effects influence public attitudes (Table S1). 
The individuals’ attitudes towards the COVID-19 vaccination varied among the stud-
ies, with acceptance ranging from 29.4% to 86%. This discrepancy could be attributed to 
variations in the study population. Sallam et al. [49] reported a very low rate of acceptance 
among people in three Arab countries, Jordan, Kuwait, and Saudi Arabia (29.4%), as com-
pared to a relatively higher acceptance of 53.1% reported in one study in Kuwait [48]. In 
contrast, as high as 86% of people in UK (mainly elderly and middle-aged at-risk adults) 
expressed their willingness to receive a vaccine [47]. This is in line with the findings of a 
recent systematic review [77] that showed a global variation in the rate of vaccine ac-
ceptance, with the Middle East being among the regions having the lowest rates. The re-
view related this finding to the widespread embrace of conspiratorial beliefs in the region, 
which subsequently resulted in negative attitudes towards vaccination. This negative at-
titude in the Arab region is alarming. 
In this review, 28 studies depicted the sociodemographic factors associated with pub-
lic attitudes toward the COVID-19 vaccination. Coherent to findings from the literature 
[78], the most common factors found to influence vaccine acceptance at the microlevel 
were age, educational level, gender, race, and income status [23–36,44–53,63,65,68,71–73]. 
More willingness to receive a vaccine was reported in the older age group 
[23,25,27,31,34,35,38,53,65], while resistance, hesitancy, and lack of intention to be vac-
cinated emerged in the younger age group [29,35,51]. This could be attributed to differ-
ences in age distribution between countries, literacy level, and the fact that older adults 
are at a higher risk of morbidity and mortality than young adults. 
Assessment of the role of gender in COVID-19 vaccine hesitancy revealed that men 
are more willing to accept the vaccine than women [28–30,38,48,49], and this held true 
across cultures (Arab countries [48,49], China [28], Ireland, and the UK [29]). Only one 
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cross-sectional study in the USA reported lower acceptance among men [32]. Women 
were reported to have adopted more negative views about vaccination [30] while men 
showed a lower belief in rumors and conspiracy theories surrounding COVID-19 and 
higher risk perception for the disease [49,77]. However, this finding should be interpreted 
with caution in light of sex distribution, as sampling bias cannot be ruled out. 
Similar to previous findings, the current review found variations in vaccine ac-
ceptance and uptake across different race and ethnic minorities. Blacks, Hispanics, Chi-
nese, Asian, non-Irish, mixed, or other ethnicities were more hesitant and more likely to 
reject the vaccines. The literature attributed this attitude to religious and cultural beliefs, 
norms, and concerns [37,79]. High education level and high-income status were associated 
with positive attitudes toward vaccination, owing to minimal barriers related to 
knowledge, health literacy, and cost concerns [23–25,27,30,35,36,42,47,49–51,63,65]. 
In addition, other factors were included, such as health condition, people with 
chronic diseases, occupation status, marital status, place of residence, women being preg-
nant or having children, and having health insurance or not. More willingness and ac-
ceptance were reported among married individuals [ 
[7,28,52], those who reside in rural or suburban areas [29,68], being employed 
[27,46,50,53,73], especially in professional and managerial occupations [50,53], being at 
risk or belonging to a vulnerable group [34,45,65], and having insurance [30,31,36,51,68]. 
Knowing these factors can provide guidance for organizations and professionals on peo-
ple and settings that need to be targeted to enhance vaccine acceptance and improve vac-
cine uptake rates [79]. 
More publications (36 studies) reported several individual factors influencing public 
attitudes towards COVID-19 vaccines. The most cited factors were beliefs 
[30,32,34,35,49,55–57,62,66,68,70], knowledge, and health literacy [23,33–35,39,57,65,68]. 
Other factors such as perceived susceptibility, threats and benefits, social, religious, and 
political views, previous exposure to flu vaccines, and lack of trust in the governments 
and companies producing the vaccines were also reported. This is consistent with findings 
from other reviews related to COVID-19 vaccines and other vaccines [77,78,80]. 
Knowledge about COVID-19 vaccines is limited as illustrated in numerous studies 
[23,33–35,39,57,65,68]. Unfavorable attitudes toward vaccination was related to misbeliefs, 
conspiracy beliefs, and antivaccine beliefs [35,47,49,56,57,62,66,68], inadequate knowledge 
and health literacy [33,57,65], lower perceived risk, threat, severity, and susceptibility 
[24,28,38,41,43,45–48,56], political conservatism, partisanship and engagement 
[29,32,54,61,66], and religious conviction [37]. Nevertheless, the factors associated with 
more vaccination acceptance included positive subjective norms and attitudes towards 
vaccination in general and COVID-19 vaccination in particular [36,56,59,66], high per-
ceived benefits [46], self-efficacy [36], institutional and government trust [25,35,37,39,59], 
previous exposure to flu or other vaccines [28,30,52,56,58], and prosocial concerns [61,70]. 
Enhancing these factors may improve the vaccination uptake rate. 
Several studies examined the role of the social network and organizational factors 
[24,25,28,31,37,42–44,64,69]. Healthcare professionals appeared to be a trusted source of 
information. Their recommendations [28,43,44,69] in addition to support of family and 
friends [31,44] play an important role in shaping perceptions and behaviors towards vac-
cination. Significant others were reported in the literature to influence one’s attitude and 
behavior. Information, acknowledgement, and recommendations from family members, 
friends, employers, and community members were associated with favorable attitudes 
and a higher uptake of vaccines [25,78,80]. 
On the other hand, the misinformation encountered, particularly on social media, the 
type and frame of massages received may influence the attitude to vaccination and inten-
tion [24,37,42,64]. Propagation of myths and conspiracy theories around vaccines and pro-
motion of the antivaccine sentiment, combined with exposure to persuasive tactics, can 
convince the person that the vaccine is harmful, as indicated by Sarah Ashfield et al. [81]. 
Accordingly, public health organizations, healthcare professionals, and media platforms 
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can collaborate to guarantee information accuracy, deliver health promotion programs to 
improve levels of health literacy to enable the target population to make an informed de-
cision. In addition, this psychosocial environmental impact implies that strategies to over-
come hesitancy can be framed within models that consider these multifaceted and multi-
leveled factors. 
Regarding vaccine characteristics, many publications included in this review focused 
on efficacy, safety, adverse effects or toxicity of the vaccines, and cost [28,35,40,43,45–
47,63,65,68,72,73], which were the most significant characteristics and concerns about 
COVID-19 vaccines. These were also common factors highlighted in other reviews about 
COVID-19 vaccines and other vaccines [77,78,80]. 
Beyond these, the present review also found other factors that further contribute to 
our understanding of the barriers to vaccination uptake. Immunity duration [68], vaccina-
tion timeframe [63], fake or low-quality vaccines [37,46], beliefs about the consequences 
[47], country of vaccine origin [68], information about inactivated vaccines [72], and 
doubts about technology used in production [37,67] allow a detailed understanding of 
how to approach vaccine-hesitant groups to increase acceptance and uptake of the vac-
cines. These concerns can be addressed via awareness campaigns guided by physicians 
and other healthcare professionals to foster trust in health authorities, assure the public, 
and illustrate the role of vaccination in acquiring herd immunity and preventing disease 
transmission. 
As illustrated above, the majority of the studies in this review addressed factors as-
sociated with vaccination attitude at the micro-meso level; however, there is a lack of pub-
lications that address the factors on the upper level of the socio-ecological model. Deter-
minants on the macro-level of the model, including policy/regulations, broad sociocul-
tural, religious, political, and environmental factors, and the influence they may exert on 
COVID-19 vaccine uptake are underexplored to date, at least in the results presented in 
our review. This gap in evidence necessitates further research to comprehensively tackle 
the issue of vaccine hesitancy. Another important output for this scoping review reflects 
the gap in clinical evidence concerning the COVID-19 vaccine efficacy, safety, and side 
effects to date, which showed an influence in shaping public hesitancy and refusal of the 
vaccines. Clinical research is needed to fill this gap and manage sharing evidence that will 
alleviate public concerns and enhance vaccine acceptance. 
The included studies reported global data which can be seen as a strength of this 
review. On the other hand, our review has some limitations. Only the articles in English 
were included; this may have potentially introduced bias or resulted in missing important 
literature. We did not include one keyword, “Antivax,” in our search strategy; however, 
when we did, only one new publication was found, therefore, this would unlikely have a 
noticeable effect on our results. The majority of the included studies are cross-sectional, 
which limits the ability to infer the causation between the various factors and public atti-
tudes towards the COVID-19 vaccination. Most of these studies used self-administered 
surveys that may lead to biases. Furthermore, uncontrolled health conditions of the target 
populations and the various global healthcare systems in the studies included in this re-
view may have had a misleading influence on the results. 
Understanding various population needs and the factors shaping public attitudes to-
wards the vaccines would support planning for evidence-based multilevel interventions 
in order to enhance the vaccine uptake globally. In our findings, we were able to report 
factors on the individual, social, and organizational levels. Future research should focus 
on exploring the cultural, economic, and political factors influencing public attitudes to-
wards the COVID-19 vaccination.   




This review highlights the complexity of the topic. Our findings show that attitudes 
toward COVID-19 vaccines is shaped by factors that are multifaceted and multileveled. A 
combination of a set of complementary multilevel interventions and engagement of di-
verse players, recipients, and settings may be helpful to improve the vaccination uptake 
to win the fight against this pandemic. 
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Appendix A 
Table A1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-
ScR) Checklist. 
Section Item Prisma-ScR Checklist ITEM Reported on Page # 
Title 
Title 1 Identify the report as a scoping review. 1 
Abstract 
Structured summary 2 
Provide a structured summary that includes (as applicable): back-
ground, objectives, eligibility criteria, sources of evidence, charting 





Describe the rationale for the review in the context of what is already 
known. Explain why the review questions/objectives lend themselves 
to a scoping review approach. 
2 
Objectives 4 
Provide an explicit statement of the questions and objectives being 
addressed with reference to their key elements (e.g., population or 
participants, concepts, and context) or other relevant key elements 
used to conceptualize the review questions and/or objectives. 
3 
Methods 
Protocol and registration 5 
Indicate whether a review protocol exists; state if and where it can be 
accessed (e.g., a Web address); and if available, provide registration 
information, including the registration number. 
3 
Eligibility criteria 6 
Specify characteristics of the sources of evidence used as eligibility 
criteria (e.g., years considered, language, and publication status), and 
provide a rationale. 
3 
Information sources * 7 
Describe all information sources in the search (e.g., databases with 
dates of coverage and contact with authors to identify additional 
sources), as well as the date the most recent search was executed. 
3 




Present the full electronic search strategy for at least 1 database, in-
cluding any limits used, such that it could be repeated. 
3 
Selection of sources of 
evidence † 
9 
State the process for selecting sources of evidence (i.e., screening and 
eligibility) included in the scoping review. 
3 
Data charting process ‡ 10 
Describe the methods of charting data from the included sources of 
evidence (e.g., calibrated forms or forms that have been tested by the 
team before their use, and whether data charting was done inde-
pendently or in duplicate) and any processes for obtaining and con-
firming data from investigators. 
4 
Data items 11 
List and define all variables for which data were sought and any as-
sumptions and simplifications made. 
4 
Critical appraisal of in-
dividual sources of evi-
dence § 
12 
If done, provide a rationale for conducting a critical appraisal of in-
cluded sources of evidence; describe the methods used and how this 
information was used in any data synthesis (if appropriate). 
NA 
Synthesis of results 13 




Selection of sources of 
evidence 
14 
Give numbers of sources of evidence screened, assessed for eligibil-
ity, and included in the review, with reasons for exclusions at each 
stage, ideally using a flow diagram. 
5 
Characteristics of 
sources of evidence 
15 
For each source of evidence, present characteristics for which data 
were charted and provide the citations. 
6 
Critical appraisal within 
sources of evidence 
16 
If done, present data on critical appraisal of included sources of evi-
dence (see item 12). 
NA 
Results of individual 
sources of evidence 
17 
For each included source of evidence, present the relevant data that 
were charted that relate to the review questions and objectives. 
8 
Synthesis of results 18 
Summarize and/or present the charting results as they relate to the 
review questions and objectives. 
13 
Discussion 
Summary of evidence 19 
Summarize the main results (including an overview of concepts, 
themes, and types of evidence available), link to the review questions 
and objectives, and consider the relevance to key groups. 
28 
Limitations 20 Discuss the limitations of the scoping review process. 30 
Conclusions 21 
Provide a general interpretation of the results with respect to the re-
view questions and objectives, as well as potential implications 




Describe sources of funding for the included sources of evidence, as 
well as sources of funding for the scoping review. Describe the role 
of the funders of the scoping review. 
31 
JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic Reviews and Meta-Analyses exten-
sion for Scoping Reviews. * Where sources of evidence (see second footnote) are compiled from, such as bibliographic 
databases, social media platforms, and Web sites. † A more inclusive/heterogeneous term used to account for the different 
types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) 
that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources 
(see first footnote). ‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 
5) refer to the process of data extraction in a scoping review as data charting. § The process of systematically examining 
research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for 
items 12 and 19 instead of “risk of bias” (which is more applicable to systematic reviews of interventions) to include and 
acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative 
research, expert opinion, and policy document).   
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